ResMed (RMD) Reports In-Line Q1 EPS

October 23, 2014 4:20 PM EDT
Get Alerts RMD Hot Sheet
Price: $226.00 --0%

Financial Fact:
Gross profit: 269.18M

Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE

ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.

For earnings history and earnings-related data on ResMed (RMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings